Unlock instant, AI-driven research and patent intelligence for your innovation.

Hybridoma cell strain secreting metronidazole monoclonal antibody and application thereof

A hybridoma cell line and metronidazole single technology, applied in the field of immunochemistry, can solve the problems of long time, high cost, professional and complex pretreatment technology, etc., and achieve the effect of high sensitivity

Active Publication Date: 2022-07-22
JIANGNAN UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these methods have high sensitivity and reliability, they require high professionalism, complex pre-processing techniques, and have the disadvantages of time-consuming and high cost.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hybridoma cell strain secreting metronidazole monoclonal antibody and application thereof
  • Hybridoma cell strain secreting metronidazole monoclonal antibody and application thereof
  • Hybridoma cell strain secreting metronidazole monoclonal antibody and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: Synthesis of Metronidazole Hapten

[0047] (1) First weigh metronidazole (MNZ, 40g, 233.9mmol) and dissolve it into anhydrous N,N-dimethylformamide (DMF, 400mL), then add N,N-dimethylformamide to the above solution Formamide dimethyl acetal (DMF-DMA, 400 mL) and trifluoroacetic acid (TFA, 2 mL) were reacted with magnetic stirring at 100 °C under nitrogen protection for 48 h. After the reaction was completed, vacuum rotary evaporation was concentrated to obtain a black color. Solid compound 1 (37 g, 69.9%).

[0048]

[0049] (2) Compound 1 (37 g, 163.7 mmol) and triethylamine (TEA, 33.1 g, 322.4 mmol) were first dissolved in dichloromethane (370 mL), and then added dropwise to the above at 0°C under nitrogen protection. Acetyl chloride (19.3 g, 245.6 mmol) was added to the solution, and the reaction was kept under magnetic stirring at room temperature overnight. After the reaction was completed, the above solution system was washed with water and saturate...

Embodiment 2

[0055] Example 2: Synthesis of Metronidazole Complete Antigen

[0056] The preparation method of metronidazole immunization antigen comprises the following steps:

[0057] (1) The metronidazole hapten MNZ-COOH (16.2 mg, 0.06 mM) of formula 1 was dissolved in N,N-dimethylformamide (DMF, 1 mL) solution, and then dissolved in N,N- 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, 34.3 mg) in dimethylformamide (DMF, 0.2 mL) and dissolved in MES (0.1 M, N-hydroxysuccinimide (NHS, 20.7 mg) in pH=4.0, 0.2 mL), and magnetically stirred at room temperature for 1 h to obtain solution A.

[0058] (2) Dissolve the carrier protein in carbonate buffer (CBS, 0.05M, pH=9.6) to obtain solution B. In this study, bovine serum albumin BSA (67mg, 0.001mM) was selected.

[0059] (3) At room temperature, slowly add solution A dropwise to solution B kept magnetic stirring, and use sodium hydroxide (0.5M) to maintain the pH of the solution between 8.5-9, and keep the magnetic stirrin...

Embodiment 3

[0067] Example 3: Preparation of Metronidazole Hybridoma Cell Line 1A10

[0068] (1) Mice immunization: Select healthy 6-8 week old Balb / C female mice for immunization. BALB / c mice were immunized by subcutaneous injection on the back after mixing and emulsification of complete metronidazole antigen with an equal amount of Freund's adjuvant. Complete Freund's adjuvant was used for the first immunization, and incomplete Freund's adjuvant was used for booster immunizations, with an interval of 21 days between each immunization. Blood was collected 7 days after the third immunization, and ic-ELISA was used to determine the serum titer and inhibition of mice. Mice with high titers and good inhibition were selected. 21 days after the fifth immunization, the immunization was performed by intraperitoneal injection, and the immune dose was required. Halved and without any adjuvants.

[0069] (2) Cell fusion and subcloning: The mouse spleen cells and mouse myeloma cells were fused by ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
correlation coefficientaaaaaaaaaa
correlation coefficientaaaaaaaaaa
Login to View More

Abstract

The invention provides a hybridoma cell strain secreting a metronidazole monoclonal antibody and application of the hybridoma cell strain, the hybridoma cell strain is preserved in Institute of Microbiology, Chinese Academy of Sciences, No.3, No.1 Yard, West Beichen Road, Chaoyang District, Beijing, the address of China General Microbiological Culture Collection Center, and the preservation number of the hybridoma cell strain is CGMCC NO. The strain is classified and named as a monoclonal cell strain, the preservation date is May 13, 2021, and the preservation number is CGMCC No.22330. The monoclonal antibody prepared from the immune antigen is high in sensitivity, a complete antigen prepared from MNZ-GA coupled carrier protein is taken as a coating antigen, and the IC50 value of the antibody in ic-Elisa is 0.075 ng / mL. The metronidazole hapten and the metronidazole antigen provided by the invention have very important significance and great value in the aspects of antibody preparation and metronidazole drug residue analysis and detection application.

Description

technical field [0001] The invention belongs to the technical field of immunochemistry, in particular to a hybridoma cell strain that secretes metronidazole monoclonal antibodies and its application. Background technique [0002] Metronidazole, as an antibiotic and antiprotozoal agent, has a significant effect on the treatment or prevention of systemic or local infections caused by anaerobic bacteria. , Eubacterium, Vironcoccus, Peptococcus and Peptostreptococcus, etc., all have killing effect on Histotrichomonas, Trichomonas, and have a certain inhibitory effect on Coccidia. Due to its remarkable clinical effect on anaerobic bacteria, metronidazole is also widely used in the treatment of diseases in livestock and poultry aquaculture. However, improper use and abuse will lead to a large amount of residues in animals, thus endangering human health. In my country, the drug residues of metronidazole in animal foods have been strictly restricted. Therefore, it is of great sign...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/20C07K16/44G01N33/53G01N33/577C07K14/765C07K14/77C07D233/92
CPCC07K16/44G01N33/5308G01N33/9446G01N33/577C07K14/765C07K14/77C07D233/92Y02A50/30
Inventor 胥传来雷咸禄匡华徐丽广马伟刘丽强宋珊珊胡拥明胥欣欣郭玲玲倪萍毕雪威郭鹏飞
Owner JIANGNAN UNIV